| Serial Number | 79381991 |
| Word Mark | GLX |
| Filing Date | Thursday, September 21, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Friday, December 20, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Downloadable software for use in data management in the medical field; downloadable computer software relating to the medical field for use in data management; software as a medical device (SaMD), downloadable, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable computer software for use in medical decision support systems, namely, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable health monitoring software; downloadable artificial intelligence software for healthcare, namely, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable machine learning software for healthcare, namely, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable system and system support software, and firmware for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable artificial intelligence and machine learning software for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable artificial intelligence software for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable artificial intelligence software for analysis of diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable software for making remote medical diagnostics; downloadable machine learning software for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable machine learning software for analysis of medical data |
| Goods and Services | Injectable pharmaceuticals for inflammatory diseases; diagnostic reagents for medical use; biological reagents for medical use; chemical reagents for medical use; diagnostic chemical reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for analytical purposes being reagents for medical purposes; reagents for microbiological analysis being reagents for veterinary purposes; antibodies for medical and veterinary purposes; pharmaceutical drugs being pharmaceutical preparations for the treatment and prevention of inflammatory diseases; anti-cancer drugs being anti-cancer preparations; drugs for medical purposes being pharmaceutical preparations for the treatment and prevention of inflammatory diseases; pharmaceutical preparations for the treatment and prevention of inflammatory diseases; pharmaceutical and natural remedy preparations for the treatment and prevention of inflammatory diseases; pharmaceutical preparations for the prevention of autoimmune disorders; reagents for blood grouping for medical purposes; pharmaceutical preparations, namely, human immune globulinfor the treatment and prevention of inflammatory diseases; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders |
| Goods and Services | Health and safety risk management in the nature of security threat analysis for the protection of individuals; health and safety risk assessment services in the nature of security threat analysis for the protection of individuals; licensing of intellectual property; licensing of industrial property rights; legal services; intellectual property licensing services; licensing of intellectual property in the field of copyrights being legal services; licensing of intellectual property in the field of trademarks being legal services |
| Goods and Services | Computer services, namely, on-site and remote management of information technology (IT) systems of others for the pharmaceutical and healthcare industries; medical and pharmacological research services; software as a service (SaaS) services featuring software platforms using artificial intelligence technology for diagnosing, predicting, prognosticating and monitoring medical conditions; DNA sequencing technology research; blood analysis services for scientific research purposes; software as a service (SaaS) featuring software using machine learning technology for diagnosing, predicting, prognosticating and monitoring medical conditions; software as a service (SaaS) services featuring software using machine learning, deep learning and deep neural network technology for diagnosing, predicting, prognosticating and monitoring medical conditions |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 27, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 27, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 27, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, October 27, 2023 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | GLX Analytix ApS |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | København N DK-2200 DK |
| Event Date | Event Description |
| Thursday, October 26, 2023 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, October 27, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, October 31, 2023 | APPLICATION FILING RECEIPT MAILED |
| Saturday, November 25, 2023 | NEW REPRESENTATIVE AT IB RECEIVED |
| Tuesday, May 14, 2024 | ASSIGNED TO EXAMINER |
| Friday, May 17, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, June 5, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Wednesday, June 5, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Monday, June 24, 2024 | REFUSAL PROCESSED BY MPU |
| Monday, June 24, 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, July 15, 2024 | REFUSAL PROCESSED BY IB |
| Thursday, November 21, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, November 21, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 21, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 20, 2024 | FINAL REFUSAL WRITTEN |
| Friday, December 20, 2024 | FINAL REFUSAL E-MAILED |
| Friday, December 20, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |